Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Use of aromatase inhibitors in management of breast cancer discussed
December 29th, 2005
Investigators discussed the use of aromatase inhibitors in the management of breast cancer. "Breast cancer is a major health problem in developed countries," scientists in Canada reported. "Endocrine therapy is a key component in the management of hormone receptor-positive disease. Although tamoxifen has historically been the gold standard in the first-line management of early and advanced breast cancer, the rise of third-generation aromatase inhibitors in the past decade has resulted in a major shift in endocrine therapy," explained N.S. Wong and colleagues, University of Toronto. "Clinical trials of aromatase inhibitors...
Source: Women's Health Weekly (2005-12-29)
|
